October 23, 2026Stocks·Bullish·regulatory approval

FDA approves Novo Nordisk's Awiqli as first once-weekly insulin for children with type 2 diabetes

The US FDA approved Novo Nordisk's Awiqli as the first and only once-weekly insulin for children aged 10 and older with type 2 diabetes.

Detected & updated continuously · Source: Nebula

Story subjects

Food and Drug AdministrationNovo Nordisk

Track sentiment and mindshare across stocks and crypto in Nebula.